Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk Grading System”

122 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 122 results

Not applicableNot Yet RecruitingNCT06276803
What this trial is testing

The LINFU® U.S. Registry for the in the General Population Without Risk Factors

Who this might be right for
Pancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Dysplasia
Adenocyte, LLC 500
Early research (Phase 1)WithdrawnNCT00521261
What this trial is testing

Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT05256641
What this trial is testing

Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaHigh-grade B-cell LymphomaTransformed Lymphoma+1 more
Jonsson Comprehensive Cancer Center 24
Early research (Phase 1)Study completedNCT02343536
What this trial is testing

A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma

Who this might be right for
Lymphoma, Large B-Cell, DiffuseLymphoma, Follicular
Celgene 59
Early research (Phase 1)Study completedNCT04139577
What this trial is testing

FMT In High-Risk Acute GVHD After ALLO HCT

Who this might be right for
Acute Graft-Versus-Host Disease (Gvhd) GradeHematopoietic Cell TransplantationFecal Microbiota Transplant
Massachusetts General Hospital 10
Not applicableStudy completedNCT00000703
What this trial is testing

Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Testing effectiveness (Phase 2)Study completedNCT01502982
What this trial is testing

Dose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Nordic Lymphoma Group 160
Testing effectiveness (Phase 2)Study completedNCT00559104
What this trial is testing

Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 60
Not applicableLooking for participantsNCT06199856
What this trial is testing

Assessment System for Sarcopenia Based on Ultrasonographic Data

Who this might be right for
SarcopeniaUltrasound
West China Hospital 1,500
Testing effectiveness (Phase 2)Looking for participantsNCT06239272
What this trial is testing

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Who this might be right for
Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+6 more
St. Jude Children's Research Hospital 139
Testing effectiveness (Phase 2)Looking for participantsNCT06736613
What this trial is testing

Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaStage III High Grade B-Cell Lymphoma+7 more
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03995147
What this trial is testing

Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma

Who this might be right for
B Cell LymphomaLymphomaLymphoma, B-Cell+2 more
University of Chicago 51
Not applicableUnknownNCT02686996
What this trial is testing

The Potential of Carnosine Supplementation in Reducing the Cardiometabolic Risk

Who this might be right for
Insulin Sensitivity
Monash University 84
Testing effectiveness (Phase 2)Study completedNCT01216683
What this trial is testing

Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma

Who this might be right for
Lymphoma
ECOG-ACRIN Cancer Research Group 289
Not applicableStudy completedNCT01417507
What this trial is testing

Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery

Who this might be right for
Adult Diffuse AstrocytomaAdult Mixed GliomaAdult Oligodendroglioma+4 more
Radiation Therapy Oncology Group 82
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Testing effectiveness (Phase 2)Study completedNCT00785330
What this trial is testing

Allo-hNHL (FluBuCy)

Who this might be right for
Non-Hodgkin's Lymphoma
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT00602667
What this trial is testing

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

Who this might be right for
Brain and Central Nervous System Tumors
St. Jude Children's Research Hospital 293
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Not applicableLooking for participantsNCT05463796
What this trial is testing

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Who this might be right for
Cancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more
Dana-Farber Cancer Institute 5,000
Load More Results